Global Drugs for Oncology Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drugs for Oncology Market Size 2017-2028

2.1.2 Drugs for Oncology Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Drugs for Oncology Segment by Type

2.2.1 Chemotherapy

2.2.2 Targeted Therapy

2.2.3 Immunotherapy (Biologic Therapy)

2.2.4 Hormonal Therapy

2.2.5 Others

2.3 Drugs for Oncology Market Size by Type

2.3.1 Drugs for Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Drugs for Oncology Market Size Market Share by Type (2017-2022)

2.4 Drugs for Oncology Segment by Application

2.4.1 Blood Cancer

2.4.2 Breast Cancer

2.4.3 Gastrointestinal Cancer

2.4.4 Prostate Cancer

2.4.5 Respiratory/Lung Cancer

2.4.6 Others

2.5 Drugs for Oncology Market Size by Application

2.5.1 Drugs for Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Drugs for Oncology Market Size Market Share by Application (2017-2022)

3 Drugs for Oncology Market Size by Player

3.1 Drugs for Oncology Market Size Market Share by Players

3.1.1 Global Drugs for Oncology Revenue by Players (2020-2022)

3.1.2 Global Drugs for Oncology Revenue Market Share by Players (2020-2022)

3.2 Global Drugs for Oncology Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Drugs for Oncology by Regions

4.1 Drugs for Oncology Market Size by Regions (2017-2022)

4.2 Americas Drugs for Oncology Market Size Growth (2017-2022)

4.3 APAC Drugs for Oncology Market Size Growth (2017-2022)

4.4 Europe Drugs for Oncology Market Size Growth (2017-2022)

4.5 Middle East & Africa Drugs for Oncology Market Size Growth (2017-2022)

5 Americas

5.1 Americas Drugs for Oncology Market Size by Country (2017-2022)

5.2 Americas Drugs for Oncology Market Size by Type (2017-2022)

5.3 Americas Drugs for Oncology Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Drugs for Oncology Market Size by Region (2017-2022)

6.2 APAC Drugs for Oncology Market Size by Type (2017-2022)

6.3 APAC Drugs for Oncology Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Drugs for Oncology by Country (2017-2022)

7.2 Europe Drugs for Oncology Market Size by Type (2017-2022)

7.3 Europe Drugs for Oncology Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Drugs for Oncology by Region (2017-2022)

8.2 Middle East & Africa Drugs for Oncology Market Size by Type (2017-2022)

8.3 Middle East & Africa Drugs for Oncology Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Drugs for Oncology Market Forecast

10.1 Global Drugs for Oncology Forecast by Regions (2023-2028)

10.1.1 Global Drugs for Oncology Forecast by Regions (2023-2028)

10.1.2 Americas Drugs for Oncology Forecast

10.1.3 APAC Drugs for Oncology Forecast

10.1.4 Europe Drugs for Oncology Forecast

10.1.5 Middle East & Africa Drugs for Oncology Forecast

10.2 Americas Drugs for Oncology Forecast by Country (2023-2028)

10.2.1 United States Drugs for Oncology Market Forecast

10.2.2 Canada Drugs for Oncology Market Forecast

10.2.3 Mexico Drugs for Oncology Market Forecast

10.2.4 Brazil Drugs for Oncology Market Forecast

10.3 APAC Drugs for Oncology Forecast by Region (2023-2028)

10.3.1 China Drugs for Oncology Market Forecast

10.3.2 Japan Drugs for Oncology Market Forecast

10.3.3 Korea Drugs for Oncology Market Forecast

10.3.4 Southeast Asia Drugs for Oncology Market Forecast

10.3.5 India Drugs for Oncology Market Forecast

10.3.6 Australia Drugs for Oncology Market Forecast

10.4 Europe Drugs for Oncology Forecast by Country (2023-2028)

10.4.1 Germany Drugs for Oncology Market Forecast

10.4.2 France Drugs for Oncology Market Forecast

10.4.3 UK Drugs for Oncology Market Forecast

10.4.4 Italy Drugs for Oncology Market Forecast

10.4.5 Russia Drugs for Oncology Market Forecast

10.5 Middle East & Africa Drugs for Oncology Forecast by Region (2023-2028)

10.5.1 Egypt Drugs for Oncology Market Forecast

10.5.2 South Africa Drugs for Oncology Market Forecast

10.5.3 Israel Drugs for Oncology Market Forecast

10.5.4 Turkey Drugs for Oncology Market Forecast

10.5.5 GCC Countries Drugs for Oncology Market Forecast

10.6 Global Drugs for Oncology Forecast by Type (2023-2028)

10.7 Global Drugs for Oncology Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Drugs for Oncology Product Offered

11.1.3 Roche Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Celgene

11.2.1 Celgene Company Information

11.2.2 Celgene Drugs for Oncology Product Offered

11.2.3 Celgene Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Celgene Main Business Overview

11.2.5 Celgene Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Drugs for Oncology Product Offered

11.3.3 Novartis Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Information

11.4.2 Bristol-Myers Squibb Drugs for Oncology Product Offered

11.4.3 Bristol-Myers Squibb Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bristol-Myers Squibb Main Business Overview

11.4.5 Bristol-Myers Squibb Latest Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson Drugs for Oncology Product Offered

11.5.3 Johnson & Johnson Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Johnson & Johnson Main Business Overview

11.5.5 Johnson & Johnson Latest Developments

11.6 Merck & Co.

11.6.1 Merck & Co. Company Information

11.6.2 Merck & Co. Drugs for Oncology Product Offered

11.6.3 Merck & Co. Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Merck & Co. Main Business Overview

11.6.5 Merck & Co. Latest Developments

11.7 AstraZeneca

11.7.1 AstraZeneca Company Information

11.7.2 AstraZeneca Drugs for Oncology Product Offered

11.7.3 AstraZeneca Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 AstraZeneca Main Business Overview

11.7.5 AstraZeneca Latest Developments

11.8 Pfizer

11.8.1 Pfizer Company Information

11.8.2 Pfizer Drugs for Oncology Product Offered

11.8.3 Pfizer Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Pfizer Main Business Overview

11.8.5 Pfizer Latest Developments

11.9 Amgen

11.9.1 Amgen Company Information

11.9.2 Amgen Drugs for Oncology Product Offered

11.9.3 Amgen Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Amgen Main Business Overview

11.9.5 Amgen Latest Developments

11.10 Eli Lilly

11.10.1 Eli Lilly Company Information

11.10.2 Eli Lilly Drugs for Oncology Product Offered

11.10.3 Eli Lilly Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Eli Lilly Main Business Overview

11.10.5 Eli Lilly Latest Developments

11.11 AbbVie

11.11.1 AbbVie Company Information

11.11.2 AbbVie Drugs for Oncology Product Offered

11.11.3 AbbVie Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 AbbVie Main Business Overview

11.11.5 AbbVie Latest Developments

11.12 Takeda

11.12.1 Takeda Company Information

11.12.2 Takeda Drugs for Oncology Product Offered

11.12.3 Takeda Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Takeda Main Business Overview

11.12.5 Takeda Latest Developments

11.13 Astellas

11.13.1 Astellas Company Information

11.13.2 Astellas Drugs for Oncology Product Offered

11.13.3 Astellas Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Astellas Main Business Overview

11.13.5 Astellas Latest Developments

11.14 Ipsen

11.14.1 Ipsen Company Information

11.14.2 Ipsen Drugs for Oncology Product Offered

11.14.3 Ipsen Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Ipsen Main Business Overview

11.14.5 Ipsen Latest Developments

11.15 Sanofi

11.15.1 Sanofi Company Information

11.15.2 Sanofi Drugs for Oncology Product Offered

11.15.3 Sanofi Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Sanofi Main Business Overview

11.15.5 Sanofi Latest Developments

11.16 Bayer

11.16.1 Bayer Company Information

11.16.2 Bayer Drugs for Oncology Product Offered

11.16.3 Bayer Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Bayer Main Business Overview

11.16.5 Bayer Latest Developments

11.17 Biogen Idec

11.17.1 Biogen Idec Company Information

11.17.2 Biogen Idec Drugs for Oncology Product Offered

11.17.3 Biogen Idec Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Biogen Idec Main Business Overview

11.17.5 Biogen Idec Latest Developments

11.18 Teva

11.18.1 Teva Company Information

11.18.2 Teva Drugs for Oncology Product Offered

11.18.3 Teva Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Teva Main Business Overview

11.18.5 Teva Latest Developments

11.19 Otsuka

11.19.1 Otsuka Company Information

11.19.2 Otsuka Drugs for Oncology Product Offered

11.19.3 Otsuka Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Otsuka Main Business Overview

11.19.5 Otsuka Latest Developments

11.20 Eisai

11.20.1 Eisai Company Information

11.20.2 Eisai Drugs for Oncology Product Offered

11.20.3 Eisai Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Eisai Main Business Overview

11.20.5 Eisai Latest Developments

11.21 Merck KGaA

11.21.1 Merck KGaA Company Information

11.21.2 Merck KGaA Drugs for Oncology Product Offered

11.21.3 Merck KGaA Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Merck KGaA Main Business Overview

11.21.5 Merck KGaA Latest Developments

11.22 Gilead Sciences

11.22.1 Gilead Sciences Company Information

11.22.2 Gilead Sciences Drugs for Oncology Product Offered

11.22.3 Gilead Sciences Drugs for Oncology Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Gilead Sciences Main Business Overview

11.22.5 Gilead Sciences Latest Developments

12 Research Findings and Conclusion

Table 1. Drugs for Oncology Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Chemotherapy

Table 3. Major Players of Targeted Therapy

Table 4. Major Players of Immunotherapy (Biologic Therapy)

Table 5. Major Players of Hormonal Therapy

Table 6. Major Players of Others

Table 7. Drugs for Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Drugs for Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Drugs for Oncology Market Size Market Share by Type (2017-2022)

Table 10. Drugs for Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Drugs for Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Drugs for Oncology Market Size Market Share by Application (2017-2022)

Table 13. Global Drugs for Oncology Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Drugs for Oncology Revenue Market Share by Player (2020-2022)

Table 15. Drugs for Oncology Key Players Head office and Products Offered

Table 16. Drugs for Oncology Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Drugs for Oncology Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Drugs for Oncology Market Size Market Share by Regions (2017-2022)

Table 21. Americas Drugs for Oncology Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Drugs for Oncology Market Size Market Share by Country (2017-2022)

Table 23. Americas Drugs for Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Drugs for Oncology Market Size Market Share by Type (2017-2022)

Table 25. Americas Drugs for Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Drugs for Oncology Market Size Market Share by Application (2017-2022)

Table 27. APAC Drugs for Oncology Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Drugs for Oncology Market Size Market Share by Region (2017-2022)

Table 29. APAC Drugs for Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Drugs for Oncology Market Size Market Share by Type (2017-2022)

Table 31. APAC Drugs for Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Drugs for Oncology Market Size Market Share by Application (2017-2022)

Table 33. Europe Drugs for Oncology Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Drugs for Oncology Market Size Market Share by Country (2017-2022)

Table 35. Europe Drugs for Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Drugs for Oncology Market Size Market Share by Type (2017-2022)

Table 37. Europe Drugs for Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Drugs for Oncology Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Drugs for Oncology Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Drugs for Oncology Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Drugs for Oncology Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Drugs for Oncology Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Drugs for Oncology Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Drugs for Oncology Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Drugs for Oncology

Table 46. Key Market Challenges & Risks of Drugs for Oncology

Table 47. Key Industry Trends of Drugs for Oncology

Table 48. Global Drugs for Oncology Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Drugs for Oncology Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Drugs for Oncology Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Drugs for Oncology Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Drugs for Oncology Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Drugs for Oncology Market Size Market Share Forecast by Application (2023-2028)

Table 54. Roche Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 55. Roche Drugs for Oncology Product Offered

Table 56. Roche Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Roche Main Business

Table 58. Roche Latest Developments

Table 59. Celgene Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 60. Celgene Drugs for Oncology Product Offered

Table 61. Celgene Main Business

Table 62. Celgene Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Celgene Latest Developments

Table 64. Novartis Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 65. Novartis Drugs for Oncology Product Offered

Table 66. Novartis Main Business

Table 67. Novartis Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Novartis Latest Developments

Table 69. Bristol-Myers Squibb Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 70. Bristol-Myers Squibb Drugs for Oncology Product Offered

Table 71. Bristol-Myers Squibb Main Business

Table 72. Bristol-Myers Squibb Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Bristol-Myers Squibb Latest Developments

Table 74. Johnson & Johnson Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 75. Johnson & Johnson Drugs for Oncology Product Offered

Table 76. Johnson & Johnson Main Business

Table 77. Johnson & Johnson Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Johnson & Johnson Latest Developments

Table 79. Merck & Co. Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 80. Merck & Co. Drugs for Oncology Product Offered

Table 81. Merck & Co. Main Business

Table 82. Merck & Co. Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Merck & Co. Latest Developments

Table 84. AstraZeneca Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 85. AstraZeneca Drugs for Oncology Product Offered

Table 86. AstraZeneca Main Business

Table 87. AstraZeneca Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. AstraZeneca Latest Developments

Table 89. Pfizer Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 90. Pfizer Drugs for Oncology Product Offered

Table 91. Pfizer Main Business

Table 92. Pfizer Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Pfizer Latest Developments

Table 94. Amgen Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 95. Amgen Drugs for Oncology Product Offered

Table 96. Amgen Main Business

Table 97. Amgen Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Amgen Latest Developments

Table 99. Eli Lilly Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 100. Eli Lilly Drugs for Oncology Product Offered

Table 101. Eli Lilly Main Business

Table 102. Eli Lilly Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Eli Lilly Latest Developments

Table 104. AbbVie Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 105. AbbVie Drugs for Oncology Product Offered

Table 106. AbbVie Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. AbbVie Main Business

Table 108. AbbVie Latest Developments

Table 109. Takeda Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 110. Takeda Drugs for Oncology Product Offered

Table 111. Takeda Main Business

Table 112. Takeda Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Takeda Latest Developments

Table 114. Astellas Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 115. Astellas Drugs for Oncology Product Offered

Table 116. Astellas Main Business

Table 117. Astellas Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Astellas Latest Developments

Table 119. Ipsen Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 120. Ipsen Drugs for Oncology Product Offered

Table 121. Ipsen Main Business

Table 122. Ipsen Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Ipsen Latest Developments

Table 124. Sanofi Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 125. Sanofi Drugs for Oncology Product Offered

Table 126. Sanofi Main Business

Table 127. Sanofi Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Sanofi Latest Developments

Table 129. Bayer Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 130. Bayer Drugs for Oncology Product Offered

Table 131. Bayer Main Business

Table 132. Bayer Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Bayer Latest Developments

Table 134. Biogen Idec Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 135. Biogen Idec Drugs for Oncology Product Offered

Table 136. Biogen Idec Main Business

Table 137. Biogen Idec Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Biogen Idec Latest Developments

Table 139. Teva Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 140. Teva Drugs for Oncology Product Offered

Table 141. Teva Main Business

Table 142. Teva Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. Teva Latest Developments

Table 144. Otsuka Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 145. Otsuka Drugs for Oncology Product Offered

Table 146. Otsuka Main Business

Table 147. Otsuka Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Otsuka Latest Developments

Table 149. Eisai Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 150. Eisai Drugs for Oncology Product Offered

Table 151. Eisai Main Business

Table 152. Eisai Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 153. Eisai Latest Developments

Table 154. Merck KGaA Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 155. Merck KGaA Drugs for Oncology Product Offered

Table 156. Merck KGaA Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 157. Merck KGaA Main Business

Table 158. Merck KGaA Latest Developments

Table 159. Gilead Sciences Details, Company Type, Drugs for Oncology Area Served and Its Competitors

Table 160. Gilead Sciences Drugs for Oncology Product Offered

Table 161. Gilead Sciences Main Business

Table 162. Gilead Sciences Drugs for Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 163. Gilead Sciences Latest Developments

List of Figures

Figure 1. Drugs for Oncology Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Drugs for Oncology Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Drugs for Oncology Market Size Market Share by Type in 2021

Figure 7. Drugs for Oncology in Blood Cancer

Figure 8. Global Drugs for Oncology Market: Blood Cancer (2017-2022) & ($ Millions)

Figure 9. Drugs for Oncology in Breast Cancer

Figure 10. Global Drugs for Oncology Market: Breast Cancer (2017-2022) & ($ Millions)

Figure 11. Drugs for Oncology in Gastrointestinal Cancer

Figure 12. Global Drugs for Oncology Market: Gastrointestinal Cancer (2017-2022) & ($ Millions)

Figure 13. Drugs for Oncology in Prostate Cancer

Figure 14. Global Drugs for Oncology Market: Prostate Cancer (2017-2022) & ($ Millions)

Figure 15. Drugs for Oncology in Respiratory/Lung Cancer

Figure 16. Global Drugs for Oncology Market: Respiratory/Lung Cancer (2017-2022) & ($ Millions)

Figure 17. Drugs for Oncology in Others

Figure 18. Global Drugs for Oncology Market: Others (2017-2022) & ($ Millions)

Figure 19. Global Drugs for Oncology Market Size Market Share by Application in 2021

Figure 20. Global Drugs for Oncology Revenue Market Share by Player in 2021

Figure 21. Global Drugs for Oncology Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Drugs for Oncology Market Size 2017-2022 ($ Millions)

Figure 23. APAC Drugs for Oncology Market Size 2017-2022 ($ Millions)

Figure 24. Europe Drugs for Oncology Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Drugs for Oncology Market Size 2017-2022 ($ Millions)

Figure 26. Americas Drugs for Oncology Value Market Share by Country in 2021

Figure 27. Americas Drugs for Oncology Consumption Market Share by Type in 2021

Figure 28. Americas Drugs for Oncology Market Size Market Share by Application in 2021

Figure 29. United States Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Drugs for Oncology Market Size Market Share by Region in 2021

Figure 34. APAC Drugs for Oncology Market Size Market Share by Application in 2021

Figure 35. China Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Drugs for Oncology Market Size Market Share by Country in 2021

Figure 42. Europe Drugs for Oncology Market Size Market Share by Type in 2021

Figure 43. Europe Drugs for Oncology Market Size Market Share by Application in 2021

Figure 44. Germany Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Drugs for Oncology Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Drugs for Oncology Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Drugs for Oncology Market Size Market Share by Application in 2021

Figure 52. Egypt Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Drugs for Oncology Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 58. APAC Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 59. Europe Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 61. United States Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 62. Canada Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 65. China Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 66. Japan Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 67. Korea Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 69. India Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 70. Australia Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 71. Germany Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 72. France Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 73. UK Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 74. Italy Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 75. Russia Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 76. Spain Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 79. Israel Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Drugs for Oncology Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Drugs for Oncology Market Size 2023-2028 ($ Millions)